Erasca (ERAS) Amortizatization of Intangibles (2020 - 2026)
Erasca (ERAS) posted Amortizatization of Intangibles of $746000.0 for Q1 2026, up 28.62% on a QoQ basis from $580000.0 in Q4 2025, and down 62.44% year-over-year from $2.0 million in Q1 2025.
Erasca (ERAS) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Erasca's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $746000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 62.44% year-over-year to $746000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (down 58.34% YoY) and the FY2025 annual result came in at $5.1 million, down 46.96% from the prior year.
- Amortizatization of Intangibles was $746000.0 for Q1 2026 at Erasca, up from $580000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.5 million in Q3 2024 and bottomed at -$17000.0 in Q1 2022.
- A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles surged 11658.33% — and 2025, when it sank 75.35%.
- Erasca's Amortizatization of Intangibles stood at $825000.0 in 2022, then jumped by 166.06% to $2.2 million in 2023, then grew by 7.2% to $2.4 million in 2024, then sank by 75.35% to $580000.0 in 2025, then climbed by 28.62% to $746000.0 in 2026.
- Business Quant data shows ERAS's Amortizatization of Intangibles at $746000.0 in Q1 2026, $580000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Erasca | 5.83 Bn | 5.58 Bn | - | 746,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 746,000.00 |
| Mar 31, 2026 | 746,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Dec 31, 2023 | 2.20 Mn |